Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02029794Completed
Randomised, open-label trial (2 arms), sponsored by University of British Columbia. Primary endpoint: Histologically confirmed cervical intra-epithelial lesions grade 2 (CIN2) or greater at 12 months. Started Mar 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02029794.